RT Journal Article
SR Electronic
T1 The effect of human mobility and control measures on the COVID-19 epidemic in China
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.02.20026708
DO 10.1101/2020.03.02.20026708
A1 Moritz U.G. Kraemer
A1 Chia-Hung Yang
A1 Bernardo Gutierrez
A1 Chieh-Hsi Wu
A1 Brennan Klein
A1 David M. Pigott
A1 open COVID-19 data working group
A1 Louis du Plessis
A1 Nuno R. Faria
A1 Ruoran Li
A1 William P. Hanage
A1 John S. Brownstein
A1 Maylis Layan
A1 Alessandro Vespignani
A1 Huaiyu Tian
A1 Christopher Dye
A1 Simon Cauchemez
A1 Oliver G. Pybus
A1 Samuel V. Scarpino
YR 2020
UL http://medrxiv.org/content/early/2020/03/06/2020.03.02.20026708.abstract
AB The ongoing COVID-19 outbreak has expanded rapidly throughout China. Major behavioral, clinical, and state interventions are underway currently to mitigate the epidemic and prevent the persistence of the virus in human populations in China and worldwide. It remains unclear how these unprecedented interventions, including travel restrictions, have affected COVID-19 spread in China. We use real-time mobility data from Wuhan and detailed case data including travel history to elucidate the role of case importation on transmission in cities across China and ascertain the impact of control measures. Early on, the spatial distribution of COVID-19 cases in China was well explained by human mobility data. Following the implementation of control measures, this correlation dropped and growth rates became negative in most locations, although shifts in the demographics of reported cases are still indicative of local chains of transmission outside Wuhan. This study shows that the drastic control measures implemented in China have substantially mitigated the spread of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementHT, OGP and MUGK acknowledge support from the Oxford Martin School. MUGK is supported by a Branco Weiss Fellowship. NRF is supported by a Sir Henry Dale Fellowship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. WPH was supported by the National Institute of General Medical Sciences (#U54GM088558).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode and data are available on the following GitHub repository: https://github.com/Emergent-Epidemics/covid19_cordon http://github.com/Emergent-Epidemics/covid19_cordon